Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THEODORE LENG

Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist

NPI
1144438987
CMS profile
566538
Location
STANFORD, CA

General Payments · PY2018–2024

$183,135.42

  • Reported across 157 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$39,434.41

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $15,690.05 15
PY2019 $2,683.69 9
PY2020 $16,774.40 8
PY2021 $36,067.16 16
PY2022 $42,882.37 44
PY2023 $29,603.34 33
PY2024 $39,434.41 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma Global Development $54.70 05/06/2024 Food and Beverage Undisputed 01/23/2026 1132965765 CMS
Astellas Pharma US Inc $137.05 03/05/2024 Food and Beverage Undisputed 01/23/2026 1139449662 CMS
Astellas Pharma US Inc $149.74 04/22/2024 Food and Beverage Undisputed 01/23/2026 1139358395 CMS
Boehringer Ingelheim International GmbH $2,550.00 01/09/2024 Consulting Fee Undisputed 01/23/2026 1117890301 CMS
Boehringer Ingelheim International GmbH $1,062.50 02/12/2024 Consulting Fee Undisputed 01/23/2026 1117890311 CMS
Boehringer Ingelheim International GmbH $637.50 03/04/2024 Consulting Fee Undisputed 01/23/2026 1117890309 CMS
Boehringer Ingelheim International GmbH $425.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1117890305 CMS
Boehringer Ingelheim International GmbH $513.42 07/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117890307 CMS
Boehringer Ingelheim International GmbH $232.67 07/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117890299 CMS
Boehringer Ingelheim International GmbH $2,975.00 11/11/2024 Consulting Fee Undisputed 01/23/2026 1117890303 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $36.63 09/13/2024 Food and Beverage Undisputed 01/23/2026 1117890297 CMS
F. Hoffmann-La Roche AG $2,747.50 05/13/2024 Consulting Fee Undisputed 01/23/2026 1133123260 CMS
F. Hoffmann-La Roche AG $17.05 07/18/2024 Food and Beverage Undisputed 01/23/2026 1133123264 CMS
F. Hoffmann-La Roche AG $840.00 07/18/2024 Consulting Fee Undisputed 01/23/2026 1133123268 CMS
F. Hoffmann-La Roche AG $2,747.50 09/18/2024 Consulting Fee Undisputed 01/23/2026 1133123273 CMS
Genentech USA, Inc. $100.33 02/09/2024 Food and Beverage Undisputed 01/23/2026 1133123247 CMS
Genentech USA, Inc. $23.41 03/20/2024 Food and Beverage Undisputed 01/23/2026 1133123256 CMS
Genentech USA, Inc. $99.52 07/17/2024 Food and Beverage Undisputed 01/23/2026 1133123243 CMS
Genentech USA, Inc. $116.08 09/13/2024 Food and Beverage Undisputed 01/23/2026 1133123252 CMS
Genentech USA, Inc. $203.51 10/17/2024 Food and Beverage Undisputed 01/23/2026 1133123277 CMS
Genentech, Inc. $506.25 01/26/2024 Consulting Fee Undisputed 01/23/2026 1133123236 CMS
Genentech, Inc. $3,150.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 1133123240 CMS
Regeneron Healthcare Solutions, Inc. $1,620.00 02/23/2024 Consulting Fee Undisputed 01/23/2026 1114098995 CMS
Regeneron Healthcare Solutions, Inc. $3,240.00 02/23/2024 Consulting Fee Undisputed 01/23/2026 1114098997 CMS
Regeneron Pharmaceuticals, Inc. $42.33 02/09/2024 Food and Beverage Undisputed 01/23/2026 1114401753 CMS
Regeneron Pharmaceuticals, Inc. $26.25 05/09/2024 Food and Beverage Undisputed 01/23/2026 1114401755 CMS
Regeneron Pharmaceuticals, Inc. $94.44 07/19/2024 Food and Beverage Undisputed 01/23/2026 1114401757 CMS
Regeneron Pharmaceuticals, Inc. $86.03 09/11/2024 Food and Beverage Undisputed 01/23/2026 1114401759 CMS
Topcon Healthcare, Inc. $3,000.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 1145882044 CMS
Topcon Healthcare, Inc. $8,000.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1145882038 CMS
Topcon Healthcare, Inc. $2,000.00 11/02/2024 Consulting Fee Undisputed 01/23/2026 1145882040 CMS
Topcon Healthcare, Inc. $2,000.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1145882042 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.